SANUWAVE HEALTH INC
SNWVNASDAQTrading Snapshot
- Day Range
- $4.68 β $4.77
- 52-Week Range
- $3.92 β $40.87
- Volume
- $3.04B
- Avg Volume
- $2.05B
- Shares Outstanding
- 8.6M
- Next Earnings
- Dec 15, 2026
Fundamentals Snapshot
- Annual Revenue
- $44M
- Last Q Revenue
- $12M
- P/E Ratio
- 2.8
- P/S Ratio
- 0.9x
- EPS (TTM)
- $1.66
- Dividend Yield
- 0.00%
Why Investors Own SNWV
- βHigh-growth profile β revenue up +1.4% YoY with expanding US Equity exposure.
- βHealthy economics β 28% gross margin and 7% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SANUWAVE HEALTH INC
SNWVAbout SANUWAVE HEALTH INC
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
SANUWAVE HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift SNWV price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
SANUWAVE HEALTH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.